News
Vertex Pharmaceuticals has announced a broad reimbursement agreement with NHS England for ALYFTREK ...
The MHRA has approved sebetralstat (Ekterly) as the first oral, on-demand treatment for hereditary angioedema (HAE) attacks ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback